FDG-PET avidity negatively impacts survival in pStage I NSCLC in the ACOSOG Z4031 trial. Grogan, E. L., Deppen, S. A., Chen, H., Ballman, K. V., Verdial, F. C., Aldrich, M. C., Decker, P. A., Harpole, D. H., Cerfolio, R. J., Keenan, R. J., Jones, D. R., D'Amico, T. A., Shrager, J. B., Meyers, B. F., Putnam, J. B. AMER ASSOC CANCER RESEARCH. 2013

View details for DOI 10.1158/1538-7445.AM2013-LB-296

View details for Web of Science ID 000331220601221